102 related articles for article (PubMed ID: 1708443)
1. CD16+ and CD56+ cells as markers of necrotizing and crescentic glomerulonephritis and active IgA glomerulonephropathy.
Hotta O; Seki S; Taguma Y; Shimoda A; Abo T; Takahashi H
Nephron; 1991; 57(2):239-40. PubMed ID: 1708443
[No Abstract] [Full Text] [Related]
2. Accumulation of CD16-CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua.
Nishikawa K; Saito S; Morii T; Hamada K; Ako H; Narita N; Ichijo M; Kurahayashi M; Sugamura K
Int Immunol; 1991 Aug; 3(8):743-50. PubMed ID: 1716974
[TBL] [Abstract][Full Text] [Related]
3. Redistribution of natural killer (NK) cell frequency and NK cytotoxic activity in primary IgA nephropathy.
Antonaci S; Polignano A; Ottolenghi A; Tortorella C; Schena FP
Cytobios; 1992; 69(276):27-34. PubMed ID: 1374697
[TBL] [Abstract][Full Text] [Related]
4. Monocyte-induced down-modulation of CD16 and CD56 antigens on human natural killer cells and its regulation by histamine H2-receptors.
Hellstrand K; Kjellson B; Hermodsson S
Cell Immunol; 1991 Nov; 138(1):44-54. PubMed ID: 1717164
[TBL] [Abstract][Full Text] [Related]
5. Patterns of CD16 and CD56 expression in persistent expansions of CD3+NKa+ lymphocytes are predictive for clonal T-cell receptor gene rearrangements. The Yorkshire Leukaemia Group.
Sivakumaran M; Richards SJ; Hunt KM; Steed AJ; Bynoe AG; Morgan MM; Pyrah R; Roberts BE; Scott CS
Br J Haematol; 1991 Jul; 78(3):368-77. PubMed ID: 1714758
[TBL] [Abstract][Full Text] [Related]
6. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
[TBL] [Abstract][Full Text] [Related]
7. The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria.
Van Tol EA; Verspaget HW; Peña AS; Kraemer CV; Lamers CB
Eur J Immunol; 1992 Jan; 22(1):23-9. PubMed ID: 1370415
[TBL] [Abstract][Full Text] [Related]
8. Lymphoproliferative disorder of granular lymphocytes. More questions than answers.
McKenna RW
Arch Pathol Lab Med; 1992 Mar; 116(3):235-7. PubMed ID: 1371378
[No Abstract] [Full Text] [Related]
9. Selective homing of phenotypically lytic cells within nasopharyngeal carcinoma biopsies: numerous CD8- and CD16-positive cells in the tumor.
Lakhdar M; Ben Aribia MH; Maalej M; Ladgham A
Int J Cancer; 1991 Apr; 48(1):57-61. PubMed ID: 1826899
[TBL] [Abstract][Full Text] [Related]
10. Expression of the IL-2 receptor (p55 and p75) on peripheral blood lymphocytes in renal transplant recipients.
Fujiwara T; Sakagami K; Niguma T; Haisa M; Kawamura T; Kusaka S; Matsuoka J; Shiozaki S; Fujiwara T; Onoda T
Transplant Proc; 1991 Feb; 23(1 Pt 1):256-9. PubMed ID: 1824979
[No Abstract] [Full Text] [Related]
11. Natural killer cell activity in monoclonal gammopathies: relation to disease activity.
Osterborg A; Nilsson B; Björkholm M; Holm G; Mellstedt H
Eur J Haematol; 1990 Sep; 45(3):153-7. PubMed ID: 1699786
[TBL] [Abstract][Full Text] [Related]
12. CD3 negative "small agranular lymphocytes" are natural killer cells.
Inverardi L; Witson JC; Fuad SA; Winkler-Pickett RT; Ortaldo JR; Bach FH
J Immunol; 1991 Jun; 146(11):4048-52. PubMed ID: 1827820
[TBL] [Abstract][Full Text] [Related]
13. CD16+ NK cells decrease in all stages of HIV infection through a selective depletion of the CD16+CD8+CD3- subset.
Mansour I; Doinel C; Rouger P
AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1451-7. PubMed ID: 2150319
[TBL] [Abstract][Full Text] [Related]
14. Analysis of lymphocyte phenotype and T cell receptor genotype in Felty's syndrome.
Meliconi R; Kingsley GH; Pitzalis C; Sakkas L; Panayi GS
J Rheumatol; 1992 Jul; 19(7):1058-64. PubMed ID: 1380988
[TBL] [Abstract][Full Text] [Related]
15. Clonal analysis of human CD4-CD8-CD3- thymocytes highly purified from postnatal thymus.
Hori T; Spits H
J Immunol; 1991 Apr; 146(7):2116-21. PubMed ID: 1826017
[TBL] [Abstract][Full Text] [Related]
16. Changes of soluble CD16 levels in serum of HIV-infected patients: correlation with clinical and biologic prognostic factors.
Khayat D; Soubrane C; Andrieu JM; Visonneau S; Eme D; Tourani JM; Beldjord K; Weil M; Fernandez E; Jacquillat C
J Infect Dis; 1990 Mar; 161(3):430-5. PubMed ID: 2138203
[TBL] [Abstract][Full Text] [Related]
17. Morphometric evaluation of CD16-positive cells with respect to CD2 antigen coexpression.
Manara GC; Ferrari C; Pagani L; Sansoni P; Bologna G; Molinari A; Torresani C; De Panfilis G
Cell Immunol; 1990 Jun; 128(1):118-29. PubMed ID: 1971527
[TBL] [Abstract][Full Text] [Related]
18. [Chronic lymphocytic leukemia with peripheral T lymphocytes expressing CD 2+, CD 3+, CD 4-, CD 8-, CD 16+, and CD 56+ and lymph-node lymphocytes expressing CD 2+, CD 3-, CD 4-, CD 8-, CD 16+, CD 38+, and CD 56+].
Furukawa Y; Tanaka K; Hasuike T; Hirai M; Masuzawa K; Ohira H; Ota K; Yasui Y; Nakao Y; Inoue T
Rinsho Byori; 1991 May; 39(5):557-61. PubMed ID: 1712868
[TBL] [Abstract][Full Text] [Related]
19. CD56+ lymphoid cells in human first trimester pregnancy decidua as a source of novel transforming growth factor-beta 2-related immunosuppressive factors.
Clark DA; Vince G; Flanders KC; Hirte H; Starkey P
Hum Reprod; 1994 Dec; 9(12):2270-7. PubMed ID: 7536211
[TBL] [Abstract][Full Text] [Related]
20. [A case of sarcoidosis with increased CD3+ WT31- CD16+ lymphocytes].
Yoshida T; Okabe H; Ochi Y; Hosoda T; Fujiyama Y; Hosoda S
Rinsho Byori; 1991 Jun; 39(6):675-7. PubMed ID: 1831868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
